Home
/
Roivant Sciences Ltd.
/
Financials
/
Quarterly
Roivant Sciences Ltd. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Roivant Sciences Ltd. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Dec 31, 2025
$2.00M
Feb 6, 2026
Q2
2025
Sep 30, 2025
$1.57M
Nov 10, 2025
Q1
2025
Jun 30, 2025
$2.17M
Aug 11, 2025
Q3
2025
Dec 31, 2024
$9.02M
Feb 6, 2026
Q2
2025
Sep 30, 2024
$4.48M
Nov 10, 2025
Q1
2025
Jun 30, 2024
$7.99M
Aug 11, 2025
Q3
2024
Dec 31, 2023
$15.56M
Feb 10, 2025
Q2
2024
Sep 30, 2023
$3.65M
Nov 12, 2024
Q1
2024
Jun 30, 2023
$21.62M
Aug 9, 2024
Q3
2023
Dec 31, 2022
$17.05M
Feb 13, 2024
Q2
2023
Sep 30, 2022
$12.53M
Nov 13, 2023
Q1
2023
Jun 30, 2022
$4.32M
Aug 14, 2023
Q3
2022
Dec 31, 2021
$24.34M
Feb 13, 2023
Q2
2022
Sep 30, 2021
$13.99M
Nov 14, 2022
Q1
2022
Jun 30, 2021
$7.74M
Aug 15, 2022
Q3
2021
Dec 31, 2020
$5.75M
Feb 14, 2022
Q2
2021
Sep 30, 2020
$1.32M
Nov 15, 2021
Q1
2021
Jun 30, 2020
$1.58M
Sep 21, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Dec 31, 2025
($265.89M)
Feb 6, 2026
Q2
2025
Sep 30, 2025
($113.52M)
Nov 10, 2025
Q1
2025
Jun 30, 2025
($223.36M)
Aug 11, 2025
Q3
2025
Dec 31, 2024
$169.38M
Feb 6, 2026
Q2
2025
Sep 30, 2024
($230.18M)
Nov 10, 2025
Q1
2025
Jun 30, 2024
$95.30M
Aug 11, 2025
Q3
2024
Dec 31, 2023
$5.10B
Feb 10, 2025
Q2
2024
Sep 30, 2023
($304.33M)
Nov 12, 2024
Q1
2024
Jun 30, 2023
($291.82M)
Aug 9, 2024
Q3
2023
Dec 31, 2022
($352.01M)
Feb 13, 2024
Q2
2023
Sep 30, 2022
($291.59M)
Nov 13, 2023
Q1
2023
Jun 30, 2022
($331.81M)
Aug 14, 2023
Q3
2022
Dec 31, 2021
($284.54M)
Feb 13, 2023
Q2
2022
Sep 30, 2021
($208.48M)
Nov 14, 2022
Q1
2022
Jun 30, 2021
($82.18M)
Aug 15, 2022
Q3
2021
Dec 31, 2020
($261.03M)
Feb 14, 2022
Q2
2021
Sep 30, 2020
($35.40M)
Nov 15, 2021
Q1
2021
Jun 30, 2020
($3.24M)
Sep 21, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Dec 31, 2025
($339.15M)
Feb 6, 2026
Q2
2025
Sep 30, 2025
($306.23M)
Nov 10, 2025
Q1
2025
Jun 30, 2025
($284.92M)
Aug 11, 2025
Q3
2025
Dec 31, 2024
($274.38M)
Feb 6, 2026
Q2
2025
Sep 30, 2024
($341.71M)
Nov 10, 2025
Q1
2025
Jun 30, 2024
($102.24M)
Aug 11, 2025
Q3
2024
Dec 31, 2023
$5.13B
Feb 10, 2025
Q2
2024
Sep 30, 2023
($213.89M)
Nov 12, 2024
Q1
2024
Jun 30, 2023
($276.41M)
Aug 9, 2024
Q3
2023
Dec 31, 2022
($378.08M)
Feb 13, 2024
Q2
2023
Sep 30, 2022
($280.77M)
Nov 13, 2023
Q1
2023
Jun 30, 2022
($282.31M)
Aug 14, 2023
Q3
2022
Dec 31, 2021
($246.02M)
Feb 13, 2023
Q2
2022
Sep 30, 2021
($684.43M)
Nov 14, 2022
Q1
2022
Jun 30, 2021
($154.39M)
Aug 15, 2022
Q3
2021
Dec 31, 2020
($259.07M)
Feb 14, 2022
Q2
2021
Sep 30, 2020
($156.54M)
Nov 15, 2021
Q1
2021
Jun 30, 2020
($114.45M)
Sep 21, 2021